Results 151 to 160 of about 11,360 (208)

A systematic review and meta-analysis of clinical trials comparing arterolane-piperaquine vs. artemether-lumefantrine for the treatment of uncomplicated falciparum malaria. [PDF]

J Postgrad Med
Mondal A, Basu A, Modak DC, Goswami RP.
europepmc   +1 more source

Population pharmacokinetics of artemether-lumefantrine plus amodiaquine in patients with uncomplicated Plasmodium falciparum malaria. [PDF]

Br J Clin Pharmacol
Ding J, Hoglund RM, van der Pluijm RW, Callery JJ, Peto TJ, Tripura R, Das S, Châu NH, Promnarate C, Mukaka M, Dysoley L, Fanello C, Onyamboko MA, Anvikar AR, Mayxay M, Smithuis F, von Seidlein L, Dhorda M, Amaratunga C, Faiz MA, Nghia HDT, White NJ, Day NPJ, Dondorp AM, Tarning J.   +24 more
europepmc   +1 more source

Integrative preclinical strategy for pharmacokinetic profiling and candidate selection of 3-hydroxypropanamidines: a promising antimalarial class. [PDF]

Malar J
Moritz A, Hirn-Derksen B, Klein S, Held J, Wittlin S, Rottmann M, Kurz T, Burckhardt BB.   +7 more
europepmc   +1 more source

Pharmacokinetics and Pharmacodynamics of Antimalarial Agents: Optimizing Combination Therapies to Overcome Resistance Mechanisms. [PDF]

J Clin Pharmacol
Pica K, Grundmann O, Azeredo FJ.
europepmc   +1 more source

Residual antimalarial drug concentrations before treatment in malaria patients in Asia and Africa: A systematic review and meta-analysis depicting its implication for drug pressure. [PDF]

Parasite Epidemiol Control
Marwa KJ, Zinga M, Mnkungwe HR, Mutagonda R, Kapesa A, Mwaiswelo RO, Mmbando B, Lusingu JPA, Kamugisha E.   +8 more
europepmc   +1 more source

Immunomodulation Therapy to Treat Severe Malaria With Multiple Organ Failure. [PDF]

Crit Care Explor
Camara S, Buck A, Burrell M, Humes HD, Goldstein SL, Myers CN, Humes M.   +6 more
europepmc   +1 more source

Quantification of cure for pharmacodynamic models of antimalarial drugs: Deterministic versus stochastic approaches. [PDF]

Br J Clin Pharmacol
Tully MK, Commons RJ, Simpson JA, Price DJ.   +3 more
europepmc   +1 more source

Genomic Surveillance of malaria reveals localized sporadic emergence of artemisinin partial resistance and wide-spread sulfadoxine-pyrimethamine resistance in Ghana

Dorvi IN, Kudakpo AY, Mensah C, Ngoi JM, Bandoh K, Ayeke DY, Mpere ME, Kuma CMK, Ahmed O, Sakyi M, Bamfo-Ennin R, Donkor E, Malm F, Ampeh EM, Mettle DNA, Yemi B, Tei-Maya F, Amoako EK, Unlu E, Dzabeng F, Morang’a CM, Amuzu DSY, Awandare GA, Amambua-Ngwa A, Amenga-Etego LN.   +24 more
europepmc   +1 more source

Gametocyte production and infectivity among Ugandan malaria patients infected with P. falciparum with partial resistance to artemisinins

Ayo D, Blanken SL, Onyige I, Musasizi E, Proellochs N, Katairo T, Kiyaga S, Nsengimaana B, Wiringlimanna I, Semakumba FD, Ssewanyana I, Lanke K, Opiyo D, Kamya MR, Dondorp A, Etwop T, Okot SG, Greenhouse B, Huang L, Briggs J, de Vries LE, Dorsey G, Drakeley C, Rosenthal PJ, Conrad MD, Arinaitwe E, Okao M, Bousema T.   +27 more
europepmc   +1 more source

Estimating the changing prevalence of molecular markers of artemisinin partial resistance in Plasmodium falciparum malaria in Sub-Saharan Africa

Harrison LE, Golding N, Hao T, Botha I, van Wyk S, Mategula D, Dahal P, Raman J, Weiss DJ, Barnes KI, Guérin PJ, Flegg JA.   +11 more
europepmc   +1 more source